chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever of 101.4°F; Chills; Body ache; Headaches; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), HEADACHE (Headaches), FATIGUE (Fatigue), PYREXIA (fever of 101.4°F) and CHILLS (Chills) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN (Body ache), HEADACHE (Headaches) and FATIGUE (Fatigue). On 18-Mar-2021, the patient experienced PYREXIA (fever of 101.4°F) and CHILLS (Chills). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Headache and Ache, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Fever and Chills, at an unspecified dose and frequency. At the time of the report, PAIN (Body ache), HEADACHE (Headaches), FATIGUE (Fatigue), PYREXIA (fever of 101.4°F) and CHILLS (Chills) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 101.4 f (High) 101.4 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified vitamins.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information use was not reported.  Treatment information was not provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fear of disease, Insomnia, Pain in extremity, Palpitations, Pulse abnormal
Clinical narrative: worse at night; trouble sleeping; could hear her heartbeat in her head, and it "would drive her nuts"; palpitations scare her; palpitations; usual sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitations), PALPITATIONS (worse at night), PAIN IN EXTREMITY (usual sore arm), INSOMNIA (trouble sleeping) and PULSE ABNORMAL (could hear her heartbeat in her head, and it "would drive her nuts") in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Low blood pressure and GERD. Concurrent medical conditions included Sulfonamide allergy and Food allergy (Crab meat allergy).    On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (usual sore arm). On 25-Feb-2021, the patient experienced PALPITATIONS (palpitations), INSOMNIA (trouble sleeping), PULSE ABNORMAL (could hear her heartbeat in her head, and it "would drive her nuts") and FEAR OF DISEASE (palpitations scare her). On an unknown date, the patient experienced PALPITATIONS (worse at night). At the time of the report, PALPITATIONS (palpitations), PALPITATIONS (worse at night), PAIN IN EXTREMITY (usual sore arm), INSOMNIA (trouble sleeping), PULSE ABNORMAL (could hear her heartbeat in her head, and it "would drive her nuts") and FEAR OF DISEASE (palpitations scare her) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided   This case was linked to MOD-2021-049358 (Patient Link).
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Dyspnoea, Pyrexia
Clinical narrative: Jaw started to lock; Body was shaking badly; Shortness of breath; Felt like chills; Fever of 100.8 to 101; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), TRISMUS (Jaw started to lock), TREMOR (Body was shaking badly), DYSPNOEA (Shortness of breath) and CHILLS (Felt like chills) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in January 2021. Concomitant products included VITAMINS NOS for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). On 17-Mar-2021, the patient experienced TRISMUS (Jaw started to lock), TREMOR (Body was shaking badly), DYSPNOEA (Shortness of breath), CHILLS (Felt like chills) and PYREXIA (Fever of 100.8 to 101). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Chills, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), TRISMUS (Jaw started to lock), TREMOR (Body was shaking badly), DYSPNOEA (Shortness of breath), CHILLS (Felt like chills) and PYREXIA (Fever of 100.8 to 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Body temperature: 100.8 (High) 101 and 101 (High) 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified asthma inhaler
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Trismus
Clinical narrative: Jaw started to lock; Body was shaking badly; Shortness of breath; Felt like chills; Fever of 100.8 to 101; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), TRISMUS (Jaw started to lock), TREMOR (Body was shaking badly), DYSPNOEA (Shortness of breath) and CHILLS (Felt like chills) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in January 2021. Concomitant products included VITAMINS NOS for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). On 17-Mar-2021, the patient experienced TRISMUS (Jaw started to lock), TREMOR (Body was shaking badly), DYSPNOEA (Shortness of breath), CHILLS (Felt like chills) and PYREXIA (Fever of 100.8 to 101). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Chills, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), TRISMUS (Jaw started to lock), TREMOR (Body was shaking badly), DYSPNOEA (Shortness of breath), CHILLS (Felt like chills) and PYREXIA (Fever of 100.8 to 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Body temperature: 100.8 (High) 101 and 101 (High) 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified asthma inhaler
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymph node palpable, Lymphadenopathy, Vaccination site erythema, Vaccination site mass
Clinical narrative: (injection site) red; Inflamed lymph nodes in the right side of the neck; (lymph nodes) palpable; (lymph nodes) painful; (injection site) hot; Little tumoration in the injection site; Pain in the injection site; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH ((injection site) hot, VACCINATION SITE MASS Little tumoration in the injection site, VACCINATION SITE PAIN Pain in the injection site), VACCINATION SITE ERYTHEMA ((injection site) red / and LYMPHADENOPATHY (Inflamed lymph nodes in the right side of the neck in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer. Concurrent medical conditions included Penicillin allergy, Penicillin allergy (penicillin derivatives), Drug allergy (Ibuprofen), Drug allergy (diclofenac), Pollen allergy, Dust allergy, Insect bite NOS (mites) and Food allergy. Concomitant products included LEVOTHYROXINE for Hypothyroidism, COLECALCIFEROL (VITAMIN D3 1000) for Osteopenia.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE MASS Little tumoration in the injection site) and VACCINATION SITE PAIN Pain in the injection site. On 17-Mar-2021, the patient experienced VACCINATION SITE WARMTH ((injection site) hot, VACCINATION SITE ERYTHEMA ((injection site) red, LYMPHADENOPATHY (Inflamed lymph nodes in the right side of the neck, LYMPH NODE PALPABLE ((lymph nodes) palpable and LYMPH NODE PAIN ((lymph nodes) painful. The patient was treated with NIMESULIDE on 17-Mar-2021 at a dose of 1 dosage form. At the time of the report, VACCINATION SITE WARMTH ((injection site) hot, VACCINATION SITE MASS Little tumoration in the injection site, VACCINATION SITE PAIN, Pain in the injection site), VACCINATION SITE ERYTHEMA ((injection site) red, LYMPHADENOPATHY (Inflamed lymph nodes in the right side of the neck, LYMPH NODE PALPABLE ((lymph nodes) palpable, and LYMPH NODE PAIN ((lymph nodes) painful outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site warmth
Clinical narrative: (injection site) red; Inflamed lymph nodes in the right side of the neck; (lymph nodes) palpable; (lymph nodes) painful; (injection site) hot; Little tumoration in the injection site; Pain in the injection site; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH ((injection site) hot, VACCINATION SITE MASS Little tumoration in the injection site, VACCINATION SITE PAIN Pain in the injection site), VACCINATION SITE ERYTHEMA ((injection site) red / and LYMPHADENOPATHY (Inflamed lymph nodes in the right side of the neck in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer. Concurrent medical conditions included Penicillin allergy, Penicillin allergy (penicillin derivatives), Drug allergy (Ibuprofen), Drug allergy (diclofenac), Pollen allergy, Dust allergy, Insect bite NOS (mites) and Food allergy. Concomitant products included LEVOTHYROXINE for Hypothyroidism, COLECALCIFEROL (VITAMIN D3 1000) for Osteopenia.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE MASS Little tumoration in the injection site) and VACCINATION SITE PAIN Pain in the injection site. On 17-Mar-2021, the patient experienced VACCINATION SITE WARMTH ((injection site) hot, VACCINATION SITE ERYTHEMA ((injection site) red, LYMPHADENOPATHY (Inflamed lymph nodes in the right side of the neck, LYMPH NODE PALPABLE ((lymph nodes) palpable and LYMPH NODE PAIN ((lymph nodes) painful. The patient was treated with NIMESULIDE on 17-Mar-2021 at a dose of 1 dosage form. At the time of the report, VACCINATION SITE WARMTH ((injection site) hot, VACCINATION SITE MASS Little tumoration in the injection site, VACCINATION SITE PAIN, Pain in the injection site), VACCINATION SITE ERYTHEMA ((injection site) red, LYMPHADENOPATHY (Inflamed lymph nodes in the right side of the neck, LYMPH NODE PALPABLE ((lymph nodes) palpable, and LYMPH NODE PAIN ((lymph nodes) painful outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site erythema, Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of chills, myalgia (muscle aches), injection site rash (patch on the injection site), injection site erythema (big red patch on the injection site) and injection site warmth (warm itchy patch on the injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 029A21A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Mar 6, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 6, 2021, patient experienced chills, myalgia (muscle aches) and pain. On Mar 17, 2021, patient experienced injection site rash (patch on the injection site),  injection site erythema (big red patch on the injection site), injection site warmth (warm itchy patch on the injection site) and injection site pruritus (itchy patch on the injection site). At the time of the report, chills, myalgia (muscle aches), injection site rash (patch on the injection site), injection site erythema (big red patch on the injection site), injection site warmth (warm itchy patch on the injection site), injection site pruritus (itchy patch on the injection site) and pain outcome: unknown/not provided The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular:  unknown. No concomitant product and treatment information reported.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of chills, myalgia (muscle aches), injection site rash (patch on the injection site), injection site erythema (big red patch on the injection site) and injection site warmth (warm itchy patch on the injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 029A21A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Mar 6, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 6, 2021, patient experienced chills, myalgia (muscle aches) and pain. On Mar 17, 2021, patient experienced injection site rash (patch on the injection site),  injection site erythema (big red patch on the injection site), injection site warmth (warm itchy patch on the injection site) and injection site pruritus (itchy patch on the injection site). At the time of the report, chills, myalgia (muscle aches), injection site rash (patch on the injection site), injection site erythema (big red patch on the injection site), injection site warmth (warm itchy patch on the injection site), injection site pruritus (itchy patch on the injection site) and pain outcome: unknown/not provided The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular:  unknown. No concomitant product and treatment information reported.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chills, Diarrhoea, Eye pain, Feeling abnormal
Clinical narrative: Anxiety; Rapid Heart Beat; Diarrhea; Hot Flashes; Unbalanced; Teeth hurt; eyes hurt; jaws hurt; Gums hurt; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), HEART RATE INCREASED (Rapid Heart Beat), DIARRHOEA (Diarrhea), HOT FLUSH (Hot Flashes) and FEELING ABNORMAL (Unbalanced) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced ANXIETY (Anxiety), DIARRHOEA (Diarrhea), HOT FLUSH (Hot Flashes), FEELING ABNORMAL (Unbalanced), TOOTHACHE (Teeth hurt), EYE PAIN (eyes hurt) and PAIN IN JAW (jaws hurt). 17-Mar-2021, the patient experienced HEART RATE INCREASED (Rapid Heart Beat), GINGIVAL PAIN (Gums hurt) and CHILLS (Chills). At the time of the report, ANXIETY (Anxiety), HEART RATE INCREASED (Rapid Heart Beat), DIARRHOEA (Diarrhea), HOT FLUSH (Hot Flashes), FEELING ABNORMAL (Unbalanced), TOOTHACHE (Teeth hurt), EYE PAIN (eyes hurt), PAIN IN JAW (jaws hurt), GINGIVAL PAIN (Gums hurt) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Gingival pain, Heart rate increased, Hot flush, Pain in jaw, Toothache
Clinical narrative: Anxiety; Rapid Heart Beat; Diarrhea; Hot Flashes; Unbalanced; Teeth hurt; eyes hurt; jaws hurt; Gums hurt; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), HEART RATE INCREASED (Rapid Heart Beat), DIARRHOEA (Diarrhea), HOT FLUSH (Hot Flashes) and FEELING ABNORMAL (Unbalanced) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced ANXIETY (Anxiety), DIARRHOEA (Diarrhea), HOT FLUSH (Hot Flashes), FEELING ABNORMAL (Unbalanced), TOOTHACHE (Teeth hurt), EYE PAIN (eyes hurt) and PAIN IN JAW (jaws hurt). 17-Mar-2021, the patient experienced HEART RATE INCREASED (Rapid Heart Beat), GINGIVAL PAIN (Gums hurt) and CHILLS (Chills). At the time of the report, ANXIETY (Anxiety), HEART RATE INCREASED (Rapid Heart Beat), DIARRHOEA (Diarrhea), HOT FLUSH (Hot Flashes), FEELING ABNORMAL (Unbalanced), TOOTHACHE (Teeth hurt), EYE PAIN (eyes hurt), PAIN IN JAW (jaws hurt), GINGIVAL PAIN (Gums hurt) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Erythema, Neck pain, Pain in extremity
Clinical narrative: pain in shoulder and left side of neck; left arm hurts and is red; pain in shoulder and left side of neck; Dizzy; pain in right arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Mar-2021 and was forwarded to Moderna on 19-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), PAIN IN EXTREMITY (pain in right arm), NECK PAIN (pain in shoulder and left side of neck), PAIN IN EXTREMITY (left arm hurts and is red) and ERYTHEMA (left arm hurts and is red) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced DIZZINESS (Dizzy) and PAIN IN EXTREMITY (pain in right arm). On an unknown date, the patient experienced NECK PAIN (pain in shoulder and left side of neck), PAIN IN EXTREMITY (left arm hurts and is red), ERYTHEMA (left arm hurts and is red) and ARTHRALGIA (pain in shoulder and left side of neck). The patient was treated with PARACETAMOL (TYLENOL) for Dizzy and Pain in arm, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizzy) and PAIN IN EXTREMITY (pain in right arm) had resolved and NECK PAIN (pain in shoulder and left side of neck), PAIN IN EXTREMITY (left arm hurts and is red), ERYTHEMA (left arm hurts and is red) and ARTHRALGIA (pain in shoulder and left side of neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Pain
Clinical narrative: Diarrhea; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and PAIN (Soreness) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) and PAIN (Soreness). At the time of the report, DIARRHOEA (Diarrhea) and PAIN (Soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant produces were reported. No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Coagulation test, Coagulation time abnormal
Clinical narrative: spike up to 7.7 to 8.1 which is usually 2.5; This spontaneous case was reported by a consumer and describes the occurrence of COAGULATION TIME ABNORMAL (spike up to 7.7 to 8.1 which is usually 2.5) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included WARFARIN for an unknown indication.    On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced COAGULATION TIME ABNORMAL (spike up to 7.7 to 8.1 which is usually 2.5). At the time of the report, COAGULATION TIME ABNORMAL (spike up to 7.7 to 8.1 which is usually 2.5) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Coagulation test: 7.7 (abnormal) 7.7 and 8.1 (abnormal) 8.1.         The patient reported she was on warfarin and on 18-Mar-2021, she went in for her blood test (unspecified) which spiked up to levels of 7.7 to 8.1. Her normal level was 2.5.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chills, Eye pain, Muscle spasms, Musculoskeletal stiffness
Clinical narrative: wasn't able to move his neck or have a full range of motion in his neck/back problems; Ache in his right foot; sinus issues and pressure in his face; mucus which he states is a sign of infection; Sore neck; eye socket hurting; Nose dripping; A sore throat; Foot cramps; He is smelling an offensive smell; back problems, sore neck and back; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (wasn't able to move his neck or have a full range of motion in his neck/back problems), PAIN IN EXTREMITY (Ache in his right foot), PARANASAL SINUS DISCOMFORT (sinus issues and pressure in his face), SECRETION DISCHARGE (mucus which he states is a sign of infection) and NECK PAIN (Sore neck) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (wasn't able to move his neck or have a full range of motion in his neck/back problems), PAIN IN EXTREMITY (Ache in his right foot), PARANASAL SINUS DISCOMFORT (sinus issues and pressure in his face), SECRETION DISCHARGE (mucus which he states is a sign of infection), NECK PAIN (Sore neck), EYE PAIN (eye socket hurting), RHINITIS (Nose dripping), OROPHARYNGEAL PAIN (A sore throat), MUSCLE SPASMS (Foot cramps), PAROSMIA (He is smelling an offensive smell), BACK PAIN (back problems, sore neck and back) and CHILLS (Chills). At the time of the report, MUSCULOSKELETAL STIFFNESS (wasn't able to move his neck or have a full range of motion in his neck/back problems), PAIN IN EXTREMITY (Ache in his right foot), PARANASAL SINUS DISCOMFORT (sinus issues and pressure in his face), SECRETION DISCHARGE (mucus which he states is a sign of infection), NECK PAIN (Sore neck), EYE PAIN (eye socket hurting), RHINITIS (Nose dripping), OROPHARYNGEAL PAIN (A sore throat), MUSCLE SPASMS (Foot cramps), PAROSMIA (He is smelling an offensive smell), BACK PAIN (back problems, sore neck and back) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. The patient was reported to use sinus medications and vapor machine as treatment for the events. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Oropharyngeal pain, Pain in extremity, Paranasal sinus discomfort, Parosmia
Clinical narrative: wasn't able to move his neck or have a full range of motion in his neck/back problems; Ache in his right foot; sinus issues and pressure in his face; mucus which he states is a sign of infection; Sore neck; eye socket hurting; Nose dripping; A sore throat; Foot cramps; He is smelling an offensive smell; back problems, sore neck and back; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (wasn't able to move his neck or have a full range of motion in his neck/back problems), PAIN IN EXTREMITY (Ache in his right foot), PARANASAL SINUS DISCOMFORT (sinus issues and pressure in his face), SECRETION DISCHARGE (mucus which he states is a sign of infection) and NECK PAIN (Sore neck) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (wasn't able to move his neck or have a full range of motion in his neck/back problems), PAIN IN EXTREMITY (Ache in his right foot), PARANASAL SINUS DISCOMFORT (sinus issues and pressure in his face), SECRETION DISCHARGE (mucus which he states is a sign of infection), NECK PAIN (Sore neck), EYE PAIN (eye socket hurting), RHINITIS (Nose dripping), OROPHARYNGEAL PAIN (A sore throat), MUSCLE SPASMS (Foot cramps), PAROSMIA (He is smelling an offensive smell), BACK PAIN (back problems, sore neck and back) and CHILLS (Chills). At the time of the report, MUSCULOSKELETAL STIFFNESS (wasn't able to move his neck or have a full range of motion in his neck/back problems), PAIN IN EXTREMITY (Ache in his right foot), PARANASAL SINUS DISCOMFORT (sinus issues and pressure in his face), SECRETION DISCHARGE (mucus which he states is a sign of infection), NECK PAIN (Sore neck), EYE PAIN (eye socket hurting), RHINITIS (Nose dripping), OROPHARYNGEAL PAIN (A sore throat), MUSCLE SPASMS (Foot cramps), PAROSMIA (He is smelling an offensive smell), BACK PAIN (back problems, sore neck and back) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. The patient was reported to use sinus medications and vapor machine as treatment for the events. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinitis, Secretion discharge
Clinical narrative: wasn't able to move his neck or have a full range of motion in his neck/back problems; Ache in his right foot; sinus issues and pressure in his face; mucus which he states is a sign of infection; Sore neck; eye socket hurting; Nose dripping; A sore throat; Foot cramps; He is smelling an offensive smell; back problems, sore neck and back; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (wasn't able to move his neck or have a full range of motion in his neck/back problems), PAIN IN EXTREMITY (Ache in his right foot), PARANASAL SINUS DISCOMFORT (sinus issues and pressure in his face), SECRETION DISCHARGE (mucus which he states is a sign of infection) and NECK PAIN (Sore neck) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (wasn't able to move his neck or have a full range of motion in his neck/back problems), PAIN IN EXTREMITY (Ache in his right foot), PARANASAL SINUS DISCOMFORT (sinus issues and pressure in his face), SECRETION DISCHARGE (mucus which he states is a sign of infection), NECK PAIN (Sore neck), EYE PAIN (eye socket hurting), RHINITIS (Nose dripping), OROPHARYNGEAL PAIN (A sore throat), MUSCLE SPASMS (Foot cramps), PAROSMIA (He is smelling an offensive smell), BACK PAIN (back problems, sore neck and back) and CHILLS (Chills). At the time of the report, MUSCULOSKELETAL STIFFNESS (wasn't able to move his neck or have a full range of motion in his neck/back problems), PAIN IN EXTREMITY (Ache in his right foot), PARANASAL SINUS DISCOMFORT (sinus issues and pressure in his face), SECRETION DISCHARGE (mucus which he states is a sign of infection), NECK PAIN (Sore neck), EYE PAIN (eye socket hurting), RHINITIS (Nose dripping), OROPHARYNGEAL PAIN (A sore throat), MUSCLE SPASMS (Foot cramps), PAROSMIA (He is smelling an offensive smell), BACK PAIN (back problems, sore neck and back) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. The patient was reported to use sinus medications and vapor machine as treatment for the events. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: lightheaded/felt dizzy almost all the time; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheaded/felt dizzy almost all the time) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced DIZZINESS (lightheaded/felt dizzy almost all the time). At the time of the report, DIZZINESS (lightheaded/felt dizzy almost all the time) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that she was on a strict diet and was unsure if that was the cause of her lightheadedness and dizziness  No concomitant medications were reported Treatment information was not provided
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at injection site after the 1st shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site after the 1st shot) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS, Hypertension and Cholesterol. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site after the 1st shot). At the time of the report, VACCINATION SITE PAIN (Soreness at injection site after the 1st shot) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Second dose : 17th March 2021 in the left arm. Lot no: 04A21A Concomitants products were used for blood pressure and cholesterol.   This case was linked to MOD-2021-049343 (Patient Link).
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Nausea
Clinical narrative: Hot burning sensation; Chills; Fever 0f 104F; Nausea; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SKIN BURNING SENSATION (Hot burning sensation), CHILLS (Chills), PYREXIA (Fever 0f 104F), NAUSEA (Nausea) and HEADACHE (Headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced SKIN BURNING SENSATION (Hot burning sensation), CHILLS (Chills), PYREXIA (Fever 0f 104F), NAUSEA (Nausea), HEADACHE (Headache) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SKIN BURNING SENSATION (Hot burning sensation), CHILLS (Chills), PYREXIA (Fever 0f 104F), NAUSEA (Nausea), HEADACHE (Headache) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Body temperature: (High) Fever of 104 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Skin burning sensation
Clinical narrative: Hot burning sensation; Chills; Fever 0f 104F; Nausea; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SKIN BURNING SENSATION (Hot burning sensation), CHILLS (Chills), PYREXIA (Fever 0f 104F), NAUSEA (Nausea) and HEADACHE (Headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced SKIN BURNING SENSATION (Hot burning sensation), CHILLS (Chills), PYREXIA (Fever 0f 104F), NAUSEA (Nausea), HEADACHE (Headache) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SKIN BURNING SENSATION (Hot burning sensation), CHILLS (Chills), PYREXIA (Fever 0f 104F), NAUSEA (Nausea), HEADACHE (Headache) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Body temperature: (High) Fever of 104 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus, Vaccination site reaction
Clinical narrative: covid arm; red; hot; itchy; Covid arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), VACCINATION SITE REACTION (covid arm), ERYTHEMA (red), FEELING HOT (hot) and PRURITUS (itchy) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE REACTION (Covid arm). On 17-Mar-2021, the patient experienced VACCINATION SITE REACTION (covid arm), ERYTHEMA (red), FEELING HOT (hot) and PRURITUS (itchy). At the time of the report, VACCINATION SITE REACTION (Covid arm), VACCINATION SITE REACTION (covid arm), ERYTHEMA (red), FEELING HOT (hot) and PRURITUS (itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication included antihistamine.    Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Outcome of events was updated(changed from unknown to resolved).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: left arm, it was inflamed, red and really itchy, for 3 weeks; left arm, it was inflamed, red and really itchy, for 3 weeks; left arm, it was inflamed, red and really itchy, for 3 weeks; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (left arm, it was inflamed, red and really itchy, for 3 weeks), ERYTHEMA (left arm, it was inflamed, red and really itchy, for 3 weeks) and PRURITUS (left arm, it was inflamed, red and really itchy, for 3 weeks) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included METFORMIN for Diabetes.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PERIPHERAL SWELLING (left arm, it was inflamed, red and really itchy, for 3 weeks) and ERYTHEMA (left arm, it was inflamed, red and really itchy, for 3 weeks). On an unknown date, the patient experienced PRURITUS (left arm, it was inflamed, red and really itchy, for 3 weeks). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (left arm, it was inflamed, red and really itchy, for 3 weeks), ERYTHEMA (left arm, it was inflamed, red and really itchy, for 3 weeks) and PRURITUS (left arm, it was inflamed, red and really itchy, for 3 weeks) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment also included Ice.     This case was linked to US-MODERNATX, INC.-MOD-2021-049424 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049424:Crosslinked for Dose 2
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Mobility decreased, Pain in extremity
Clinical narrative: soreness in the arm/ pain in the arm; cant raise arm; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm/ pain in the arm), MOBILITY DECREASED (cant raise arm) and FATIGUE (fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis rheumatoid.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in the arm/ pain in the arm), MOBILITY DECREASED (cant raise arm) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (soreness in the arm/ pain in the arm), MOBILITY DECREASED (cant raise arm) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site warmth
Clinical narrative: hot to touch left arm; hardness left arm; red welt 2-3 inches in size left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to touch left arm), VACCINATION SITE INDURATION (hardness left arm) and VACCINATION SITE ERYTHEMA (red welt 2-3 inches in size left arm) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 048AZ1A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (hot to touch left arm), VACCINATION SITE INDURATION (hardness left arm) and VACCINATION SITE ERYTHEMA (red welt 2-3 inches in size left arm). On 18-Mar-2021, VACCINATION SITE WARMTH (hot to touch left arm), VACCINATION SITE INDURATION (hardness left arm) and VACCINATION SITE ERYTHEMA (red welt 2-3 inches in size left arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications were not provided. Treatment medication included topical steroid.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Metallic taste/numbing soapy-like taste; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste/numbing soapy-like taste) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSGEUSIA (Metallic taste/numbing soapy-like taste). At the time of the report, DYSGEUSIA (Metallic taste/numbing soapy-like taste) outcome was unknown.            The patient took the second dose of the mRNA-1273, hence action taken with the vaccine in response to the events was not applicable.   No concomitant medication was reported.  No treatment medication was reported.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: arm was warm to touch; Itchiness; 2 inch hard welt; redness; pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm was warm to touch), VACCINATION SITE PAIN (pain), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE INDURATION (2 inch hard welt) and VACCINATION SITE ERYTHEMA (redness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain). On 11-Mar-2021, the patient experienced VACCINATION SITE WARMTH (arm was warm to touch), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE INDURATION (2 inch hard welt) and VACCINATION SITE ERYTHEMA (redness). On 14-Mar-2021, VACCINATION SITE WARMTH (arm was warm to touch), VACCINATION SITE PAIN (pain), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE INDURATION (2 inch hard welt) and VACCINATION SITE ERYTHEMA (redness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Blood urine present
Clinical narrative: Blood in urine; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD URINE PRESENT (Blood in urine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy since an unknown date. Concurrent medical conditions included Cancer.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced BLOOD URINE PRESENT (Blood in urine). At the time of the report, BLOOD URINE PRESENT (Blood in urine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that 4 days after receiving vaccine she experienced the event. No relevant concomitant medications were reported. No treatment information was reported.